“Philanthropic support plays a critical role in accelerating the development of these new, transformative treatments,” said ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

What will medical treatment look like in the years and decades to come? There’s a lot that remains unknown here; research can ...

The machine learning approach allowed the team to create a clustering map of stem cells versus non-stem ... other ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...

Researchers used induced pluripotent stem cells to regenerate damaged corneal cells. Three out of four patients experienced vision improvement after the treatment. The study paves the way for new ...

Using neural stem cells could help treat spinal injuries once thought to be untreatable -- a new phase 1 trial has determined this approach is safe.

Derived from stem-cell technology ... shown to increase hair-follicle cell production by 24 percent in the brand’s lab testing. Apply the side-effect-free treatment for struggling and weak ...

Study participants received a single stem cell injection in one of their affected eyes. The study showed the therapy was well tolerated: One patient had a minor complication, which corrected ...

Researchers developed spatial aging clocks to map brain cell aging, revealing how T cells accelerate aging and NSCs ...

SAN DIEGO--(BUSINESS WIRE)--Global Institute of Stem Cell Therapy and Research, Inc. known as GIOSTAR, a San Diego, California based Global organization at the forefront of stem cell research over ...